← Back to Search

Other

Blueberry Supplementation for Cognitive Decline

N/A
Recruiting
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 24 weeks post intervention
Awards & highlights

Study Summary

This trial will test if eating blueberry powder for 24 weeks can help memory & cognitive function & lower biomarkers of brain injury in older adults.

Who is the study for?
This trial is for adults aged 65-99 who can visit Brigham and Women's Hospital four times. It's not for those with blueberry allergies, recent major surgery, organ transplants, plans to move from Boston soon, dementia, severe cognitive decline or end-stage renal disease.Check my eligibility
What is being tested?
The study tests if daily consumption of blueberry powder (20g) over 24 weeks improves memory and cognitive functions in older adults compared to a controlled powder without active ingredients.See study design
What are the potential side effects?
Since the intervention involves blueberries which are generally safe, side effects might be minimal but could include potential allergic reactions or gastrointestinal discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 24 weeks post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 24 weeks post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in plasma concentration of neurofilament light (NFL) between baseline and 24 weeks
Change in plasma concentration of phosphorylated tau (pTau-181) between baseline and 24 weeks
Secondary outcome measures
Change in cognitive battery test score between baseline and 24 weeks post intervention
Change in concentration of serum non-esterified fatty acids (NEFA) between baseline and 24 weeks
Change in plasma concentration of glial fibrillary acid protein (GFAB) between baseline and 24 weeks

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Blueberry groupActive Control1 Intervention
Blueberry arm
Group II: Control groupPlacebo Group1 Intervention
Control arm

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,616 Previous Clinical Trials
11,470,888 Total Patients Enrolled

Media Library

Blueberry powder (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05764824 — N/A
Traumatic Brain Injury Research Study Groups: Control group, Blueberry group
Traumatic Brain Injury Clinical Trial 2023: Blueberry powder Highlights & Side Effects. Trial Name: NCT05764824 — N/A
Blueberry powder (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05764824 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is most likely to benefit from participating in this research?

"The aim of this medical trial is to enroll 60 elderly individuals, aged 65-99 years old, who have experienced cognitive decline. Participants must be able to go to Brigham and Women's Hospital for four clinic visits in order to qualify."

Answered by AI

What is the current size of this research cohort?

"Yes, the data on clinicaltrials.gov suggests that this medical research is currently recruiting patients. It was first published on August 1st 2023 and most recently updated four days later. This study requires 60 participants from a single location."

Answered by AI

Is there an upper age limit for participation in this experiment?

"Eligibility for this clinical trial mandates that participants be between the ages of 65 and 99. There are 93 studies open to those under 18, as well as 819 trials reserved for seniors aged above 65 years old."

Answered by AI

Can people still enroll for this trial at the present time?

"As of right now, the information posted on clinicaltrials.gov says that this study is actively seeking volunteers for enrollment. It was initially published on August 1st 2023 and most recently updated four days later."

Answered by AI
~32 spots leftby Nov 2024